Location of cancer matters in treatment

06/15/2010 | New York Times (tiered subscription model), The

Proponents of targeted cancer drugs have long said that a tumor's genetic composition, rather than its location, would someday drive treatment. But recent trials of drugs that target specific tumor mutations have failed to affect tumors with the same mutations in a different location. "We've gone through a very rapid period of high expectations, maturation and disappointments," said Dr. J. Leonard Lichtenfeld of the American Cancer Society.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC